The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face ...
Stifel downgraded LVMH (LVMUY) to Hold from Buy with a price target of EUR 710, up from EUR 680. The firm says the company’s lack of earnings ...
Stifel analysts led by Rogerio Fujimori downgraded LVMH stock from a "Buy" to a "Hold" rating, while simultaneously raising the price target to €710 from the previous €680. The adjustment comes ...
Barclays lowered the firm’s price target on LVMH (LVMUY) to EUR 780 from EUR 7,770 and keeps an Overweight rating on the shares.Maximize Your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results